US FDA to monitor clinical trial data in real time in pilot program aimed at speeding approvalsReuters • 04/28/26
Biotech Investor Alex Karnal: GLP-1 Drugs Signal ‘Trillion-Dollar Revolution' in Public Health24/7 Wall Street • 04/22/26
Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.Barrons • 03/30/26
PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 202624/7 Wall Street • 03/28/26
Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And MoreSeeking Alpha • 02/07/26
Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales OutlookZacks Investment Research • 02/04/26
VanEck Pharmaceutical Fund Bets Big on Weight-Loss Drug Market Approaching $150 Billion24/7 Wall Street • 01/23/26
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In FocusBenzinga • 12/23/25
Britain will spend more on new medicines in exchange for avoiding tariffs on U.K. pharmaceutical exports to the U.S.WSJ • 12/01/25
Ozempic—and 14 other popular prescription drugs—will cost less for Medicare after the U.S. government negotiated lower pricesWSJ • 11/25/25